BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martel JC, Gatti McArthur S. Dopamine receptor subtypes, Physiology and pharmacology: New ligands and concepts in schizophrenia. Front Pharmacol. 2020;11:1003. [PMID: 32765257 DOI: 10.3389/fphar.2020.01003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 McNulty CJ, Fallon IP, Amat J, Sanchez RJ, Leslie NR, Root DH, Maier SF, Baratta MV. Elevated prefrontal dopamine interferes with the stress-buffering properties of behavioral control in female rats. Neuropsychopharmacology 2023;48:498-507. [PMID: 36076018 DOI: 10.1038/s41386-022-01443-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nieto CT, Manchado A, Belda L, Diez D, Garrido NM. 2-Phenethylamines in Medicinal Chemistry: A Review. Molecules 2023;28. [PMID: 36677913 DOI: 10.3390/molecules28020855] [Reference Citation Analysis]
3 Jin H, Wu C, Su R, Sun T, Li X, Guo C. Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds. Molecules 2023;28. [PMID: 36677583 DOI: 10.3390/molecules28020527] [Reference Citation Analysis]
4 Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A, Kumar D, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev 2023;85:101838. [PMID: 36610558 DOI: 10.1016/j.arr.2022.101838] [Reference Citation Analysis]
5 Freyberg Z, Gittes GK. Roles of Pancreatic Islet Catecholamine Neurotransmitters in Glycemic Control and in Antipsychotic Drug-Induced Dysglycemia. Diabetes 2023;72:3-15. [PMID: 36538602 DOI: 10.2337/db22-0522] [Reference Citation Analysis]
6 Sukhanov I, Dorotenko A, Fesenko Z, Savchenko A, Efimova EV, Mor MS, Belozertseva IV, Sotnikova TD, Gainetdinov RR. Inhibition of PDE10A in a New Rat Model of Severe Dopamine Depletion Suggests New Approach to Non-Dopamine Parkinson's Disease Therapy. Biomolecules 2022;13. [PMID: 36671394 DOI: 10.3390/biom13010009] [Reference Citation Analysis]
7 Legros C, Rojas A, Dupré C, Brasseur C, Riest-Fery I, Muller O, Ortuno JC, Nosjean O, Guenin SP, Ferry G, Boutin JA. Approach to the specificity and selectivity between D2 and D3 receptors by mutagenesis and binding experiments part I: Expression and characterization of D2 and D3 receptor mutants. Protein Sci 2022;31:e4459. [PMID: 36177735 DOI: 10.1002/pro.4459] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Premkumar T, Sajitha Lulu S. Molecular Mechanisms of Emerging Therapeutic Targets in Alzheimer’s Disease: A Systematic Review. Neurochem J 2022;16:443-455. [DOI: 10.1134/s1819712422040183] [Reference Citation Analysis]
9 Bhoi JD, Goel M, Ribelayga CP, Mangel SC. Circadian clock organization in the retina: From clock components to rod and cone pathways and visual function. Progress in Retinal and Eye Research 2022. [DOI: 10.1016/j.preteyeres.2022.101119] [Reference Citation Analysis]
10 Paškan M, Rimpelová S, Svobodová Pavlíčková V, Spálovská D, Setnička V, Kuchař M, Kohout M. 4-Isobutylmethcathinone-A Novel Synthetic Cathinone with High In Vitro Cytotoxicity and Strong Receptor Binding Preference of Enantiomers. Pharmaceuticals (Basel) 2022;15. [PMID: 36558946 DOI: 10.3390/ph15121495] [Reference Citation Analysis]
11 O’day DH. Calmodulin Binding Domains in Critical Risk Proteins Involved in Neurodegeneration. CIMB 2022;44:5802-5814. [DOI: 10.3390/cimb44110394] [Reference Citation Analysis]
12 Beyer AL, Kaemmerer D, Sänger J, Lupp A. Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study. IJMS 2022;23:13503. [DOI: 10.3390/ijms232113503] [Reference Citation Analysis]
13 Xu P, Huang S, Krumm BE, Zhuang Y, Mao C, Zhang Y, Wang Y, Huang X, Liu Y, He X, Li H, Yin W, Jiang Y, Zhang Y, Roth BL, Xu HE. Structural Genomics of the Human Dopamine Receptor System.. [DOI: 10.1101/2022.10.09.511478] [Reference Citation Analysis]
14 Hettiarachchi P, Johnson MA. Characterization of D3 Autoreceptor Function in Whole Zebrafish Brain with Fast-Scan Cyclic Voltammetry. ACS Chem Neurosci 2022;13:2863-73. [PMID: 36099546 DOI: 10.1021/acschemneuro.2c00280] [Reference Citation Analysis]
15 Kim ST, Doukmak EJ, Flax RG, Gray DJ, Zirimu VN, de Jong E, Steinhardt RC. Developing Photoaffinity Probes for Dopamine Receptor D(2) to Determine Targets of Parkinson's Disease Drugs. ACS Chem Neurosci 2022;13:3008-22. [PMID: 36183275 DOI: 10.1021/acschemneuro.2c00544] [Reference Citation Analysis]
16 Zhang X, Tsuboi D, Funahashi Y, Yamahashi Y, Kaibuchi K, Nagai T. Phosphorylation Signals Downstream of Dopamine Receptors in Emotional Behaviors: Association with Preference and Avoidance. Int J Mol Sci 2022;23:11643. [PMID: 36232945 DOI: 10.3390/ijms231911643] [Reference Citation Analysis]
17 Demiral ŞB, Manza P, Biesecker E, Wiers C, Shokri-Kojori E, McPherson K, Dennis E, Johnson A, Tomasi D, Wang GJ, Volkow ND. Striatal D1 and D2 receptor availability are selectively associated with eye-blink rates after methylphenidate treatment. Commun Biol 2022;5:1015. [PMID: 36163254 DOI: 10.1038/s42003-022-03979-5] [Reference Citation Analysis]
18 Mony TJ, Elahi F, Choi JW, Park SJ. Neuropharmacological Effects of Terpenoids on Preclinical Animal Models of Psychiatric Disorders: A Review. Antioxidants (Basel) 2022;11:1834. [PMID: 36139909 DOI: 10.3390/antiox11091834] [Reference Citation Analysis]
19 Pavletić P, Semeano A, Yano H, Bonifazi A, Giorgioni G, Piergentili A, Quaglia W, Sabbieti MG, Agas D, Santoni G, Pallini R, Ricci-Vitiani L, Sabato E, Vistoli G, Del Bello F. Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma. J Med Chem 2022. [PMID: 36098685 DOI: 10.1021/acs.jmedchem.2c00840] [Reference Citation Analysis]
20 Song Z, Luo G, Han C, Jia G, Zhang B. Potential Targets and Action Mechanism of Gastrodin in the Treatment of Attention-Deficit/Hyperactivity Disorder: Bioinformatics and Network Pharmacology Analysis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-12. [DOI: 10.1155/2022/3607053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Suárez Santiago JE, Roldán GR, Picazo O. Ketamine as a pharmacological tool for the preclinical study of memory deficit in schizophrenia. Behav Pharmacol 2022. [PMID: 36094064 DOI: 10.1097/FBP.0000000000000689] [Reference Citation Analysis]
22 Boroń A, Śmiarowska M, Grzywacz A, Chmielowiec K, Chmielowiec J, Masiak J, Pawłowski T, Larysz D, Ciechanowicz A. Association of Polymorphism within the Putative miRNA Target Site in the 3'UTR Region of the DRD2 Gene with Neuroticism in Patients with Substance Use Disorder. Int J Environ Res Public Health 2022;19:9955. [PMID: 36011589 DOI: 10.3390/ijerph19169955] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 da Silva Cunha TT, Silva RR, Rodrigues DA, de Sena Murteira Pinheiro P, Kronenberger T, Sant'Anna CMR, Noël F, Fraga CAM. Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D2/D3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases. Biomolecules 2022;12:1112. [PMID: 36009006 DOI: 10.3390/biom12081112] [Reference Citation Analysis]
24 Siddiqui SA, Habiba BSP, Arshad M. Parkinson Disease: Molecular Biology, Pathophysiology and Biomarkers. Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches (First Edition) 2022. [DOI: 10.2174/9789815040913122010007] [Reference Citation Analysis]
25 Tang Q, Assali DR, Güler AD, Steele AD. Dopamine systems and biological rhythms: Let’s get a move on. Front Integr Neurosci 2022;16:957193. [DOI: 10.3389/fnint.2022.957193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Reed M, Jonz MG. Neurochemical Signalling Associated With Gill Oxygen Sensing and Ventilation: A Receptor Focused Mini-Review. Front Physiol 2022;13:940020. [DOI: 10.3389/fphys.2022.940020] [Reference Citation Analysis]
27 Veselinović T, Neuner I. Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia. CNS Drugs 2022. [PMID: 35831706 DOI: 10.1007/s40263-022-00935-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Zell L, Lainer C, Kollár J, Temml V, Schuster D. Identification of Novel Dopamine D2 Receptor Ligands—A Combined In Silico/In Vitro Approach. Molecules 2022;27:4435. [DOI: 10.3390/molecules27144435] [Reference Citation Analysis]
29 Melis MR, Sanna F, Argiolas A. Dopamine, Erectile Function and Male Sexual Behavior from the Past to the Present: A Review. Brain Sciences 2022;12:826. [DOI: 10.3390/brainsci12070826] [Reference Citation Analysis]
30 Limanaqi F, Zecchini S, Dino B, Strizzi S, Cappelletti G, Utyro O, Vanetti C, Garziano M, Saulle I, Clerici M, Biasin M. Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons. Cells 2022;11:1691. [DOI: 10.3390/cells11101691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Bigdai EV, Samoilov VO. Role of Neurotransmitters in the Functioning of Olfactory Sensory Neurons. J Evol Biochem Phys 2022;58:865-874. [DOI: 10.1134/s0022093022030206] [Reference Citation Analysis]
32 Leggieri A, García-gonzález J, Torres-perez JV, Havelange W, Hosseinian S, Mech AM, Keatinge M, Busch-nentwich EM, Brennan CH. Ankk1 Loss of Function Disrupts Dopaminergic Pathways in Zebrafish. Front Neurosci 2022;16:794653. [DOI: 10.3389/fnins.2022.794653] [Reference Citation Analysis]
33 Pathogenesis and Disease Mechanisms in Neuronal Antibody-Mediated Encephalitis. Autoimmune Encephalitis and Related Disorders of the Nervous System 2022. [DOI: 10.1017/9781108696722.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Żuk J, Bartuzi D, Silva AG, Pitucha M, Koszła O, Wróbel TM, Matosiuk D, Castro M, Kaczor AA. Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications. Pharmacol Rep 2022. [PMID: 35064921 DOI: 10.1007/s43440-021-00352-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Jones-tabah J, Mohammad H, Paulus EG, Clarke PBS, Hébert TE. The Signaling and Pharmacology of the Dopamine D1 Receptor. Front Cell Neurosci 2022;15:806618. [DOI: 10.3389/fncel.2021.806618] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Salinas AG, Lee JO, Augustin SM, Zhang S, Patriarchi T, Tian L, Morales M, Mateo Y, Lovinger DM. Sub-second striatal dopamine dynamics assessed by simultaneous fast-scan cyclic voltammetry and fluorescence biosensor.. [DOI: 10.1101/2022.01.09.475513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Orsini CA, Pyon WS, Dragone RJ, Faraji M, Wheeler AR, Pompilus M, Febo M, Bizon JL, Setlow B. Age-Related Changes in Risky Decision Making and Associated Neural Circuitry in a Rat Model. eNeuro 2023;10:ENEURO. [PMID: 36596593 DOI: 10.1523/ENEURO.0385-22.2022] [Reference Citation Analysis]
38 Jose M, Lakshmanan M. Screening Methods for the Evaluation of Antipsychotic Drugs. Introduction to Basics of Pharmacology and Toxicology 2022. [DOI: 10.1007/978-981-19-5343-9_16] [Reference Citation Analysis]
39 Zhang Y, Bebok Z. An Examination of Mechanisms by which Synonymous Mutations may Alter Protein Levels, Structure and Functions. Single Nucleotide Polymorphisms 2022. [DOI: 10.1007/978-3-031-05616-1_6] [Reference Citation Analysis]
40 Frydecka D, Misiak B, Piotrowski P, Bielawski T, Pawlak E, Kłosińska E, Krefft M, Al Noaimy K, Rymaszewska J, Moustafa AA, Drapała J. The Role of Dopaminergic Genes in Probabilistic Reinforcement Learning in Schizophrenia Spectrum Disorders. Brain Sciences 2021;12:7. [DOI: 10.3390/brainsci12010007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 da Silva SR, Kalaba P, Fabišiková A, Zehl M, Dragačević V, Dos Anjos LR, Neill PJ, Wieder M, Prado-Roller A, Gajic N, Palaretti V, da Silva GVJ, Pifl C, Lubec G, Gonzalez ERP. Synthesis and dopamine receptor binding of dihydrexidine and SKF 38393 catecholamine-based analogues. Amino Acids 2021. [PMID: 34842969 DOI: 10.1007/s00726-021-03106-4] [Reference Citation Analysis]
42 Jankowski MM, Ignatowska-jankowska BM, Glac W, Wiergowski M, Kaźmierska-grębowska P, Świergiel AH. Intravenous haloperidol and cocaine alter the distribution of T CD4+ and B lymphocytes and NKT cells in rats.. [DOI: 10.1101/2021.11.28.470229] [Reference Citation Analysis]
43 Li P, Zhao SW, Wu XS, Zhang YJ, Song L, Wu L, Liu XF, Fu YF, Wu D, Wu WJ, Zhang YH, Yin H, Cui LB, Guo F. The Association Between Lentiform Nucleus Function and Cognitive Impairments in Schizophrenia. Front Hum Neurosci 2021;15:777043. [PMID: 34744673 DOI: 10.3389/fnhum.2021.777043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Shaik AB, Boateng CA, Battiti FO, Bonifazi A, Cao J, Chen L, Chitsazi R, Ravi S, Lee KH, Shi L, Newman AH. Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D 2 /D 3 Receptor Bitopic Ligands. J Med Chem 2021;64:15313-33. [DOI: 10.1021/acs.jmedchem.1c01353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Radwan B, Jansen G, Chaudhury D. Sleep-wake dynamics pre- and post-exposure to chronic social stress. iScience 2021;24:103204. [PMID: 34703999 DOI: 10.1016/j.isci.2021.103204] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Nabinger DD, Altenhofen S, Peixoto JV, da Silva JMK, Bonan CD. Long-lasting behavioral effects of quinpirole exposure on zebrafish. Neurotoxicol Teratol 2021;88:107034. [PMID: 34600099 DOI: 10.1016/j.ntt.2021.107034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
47 Luyao H, Luesch H, Uy M. GPCR Pharmacological Profiling of Aaptamine from the Philippine Sponge Stylissa sp. Extends Its Therapeutic Potential for Noncommunicable Diseases. Molecules 2021;26:5618. [PMID: 34577088 DOI: 10.3390/molecules26185618] [Reference Citation Analysis]
48 Juza R, Stefkova K, Dehaen W, Randakova A, Petrasek T, Vojtechova I, Kobrlova T, Pulkrabkova L, Muckova L, Mecava M, Prchal L, Mezeiova E, Musilek K, Soukup O, Korabecny J. Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D2 3,4-dihydroquinolin-2(1H)-one Derivatives Related to Aripiprazole. Biomolecules 2021;11:1262. [PMID: 34572475 DOI: 10.3390/biom11091262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Latif S, Jahangeer M, Maknoon Razia D, Ashiq M, Ghaffar A, Akram M, El Allam A, Bouyahya A, Garipova L, Ali Shariati M, Thiruvengadam M, Azam Ansari M. Dopamine in Parkinson's disease. Clin Chim Acta 2021;522:114-26. [PMID: 34389279 DOI: 10.1016/j.cca.2021.08.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
50 Bueschbell B, Manga P, Penner E, Schiedel AC. Evidence for Protein-Protein Interaction between Dopamine Receptors and the G Protein-Coupled Receptor 143. Int J Mol Sci 2021;22:8328. [PMID: 34361094 DOI: 10.3390/ijms22158328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Syed AB, Brašić JR. The role of lumateperone in the treatment of schizophrenia. Ther Adv Psychopharmacol 2021;11:20451253211034019. [PMID: 34377435 DOI: 10.1177/20451253211034019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
52 Zou R, Wang X, Li S, Chan HCS, Vogel H, Yuan S. The role of metal ions in G protein‐coupled receptor signalling and drug discovery. WIREs Comput Mol Sci 2022;12. [DOI: 10.1002/wcms.1565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
53 Seeman MV. History of the dopamine hypothesis of antipsychotic action. World J Psychiatr 2021; 11(7): 355-364 [PMID: 34327128 DOI: 10.5498/wjp.v11.i7.355] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
54 Frajerman A, Scoriels L, Kebir O, Chaumette B. Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment? Int J Mol Sci 2021;22:6881. [PMID: 34206945 DOI: 10.3390/ijms22136881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Borgarelli C, Klingl YE, Escamilla-Ayala A, Munck S, Van Den Bosch L, De Borggraeve WM, Ismalaj E. Lighting Up the Plasma Membrane: Development and Applications of Fluorescent Ligands for Transmembrane Proteins. Chemistry 2021;27:8605-41. [PMID: 33733502 DOI: 10.1002/chem.202100296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Chen APF, Chen L, Kim TA, Xiong Q. Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease. Biomedicines 2021;9:647. [PMID: 34200134 DOI: 10.3390/biomedicines9060647] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
57 Magistrelli L, Ferrari M, Furgiuele A, Milner AV, Contaldi E, Comi C, Cosentino M, Marino F. Polymorphisms of Dopamine Receptor Genes and Parkinson's Disease: Clinical Relevance and Future Perspectives. Int J Mol Sci 2021;22:3781. [PMID: 33917417 DOI: 10.3390/ijms22073781] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
58 Guerrero-Bautista R, Franco-García A, Hidalgo JM, Fernández-Gómez FJ, Ribeiro Do Couto B, Milanés MV, Núñez C. Distinct Regulation of Dopamine D3 Receptor in the Basolateral Amygdala and Dentate Gyrus during the Reinstatement of Cocaine CPP Induced by Drug Priming and Social Stress. Int J Mol Sci 2021;22:3100. [PMID: 33803578 DOI: 10.3390/ijms22063100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
59 Xu P, Huang S, Mao C, Krumm BE, Zhou XE, Tan Y, Huang XP, Liu Y, Shen DD, Jiang Y, Yu X, Jiang H, Melcher K, Roth BL, Cheng X, Zhang Y, Xu HE. Structures of the human dopamine D3 receptor-Gi complexes. Mol Cell 2021;81:1147-1159.e4. [PMID: 33548201 DOI: 10.1016/j.molcel.2021.01.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 16.0] [Reference Citation Analysis]
60 Kesserwani H. Delusional Infestation Secondary to the Dopamine Agonist Ropirinole in a Patient With Parkinson's Disease: A Case Report With an Outline of the Biology of Psychosis. Cureus 2021;13:e12880. [PMID: 33633909 DOI: 10.7759/cureus.12880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Menniti FS, Chappie TA, Schmidt CJ. PDE10A Inhibitors-Clinical Failure or Window Into Antipsychotic Drug Action? Front Neurosci 2020;14:600178. [PMID: 33551724 DOI: 10.3389/fnins.2020.600178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
62 Jeremic D, Sanchez-Rodriguez I, Jimenez-Diaz L, Navarro-Lopez JD. Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system. Pharmacol Ther 2021;223:107808. [PMID: 33476640 DOI: 10.1016/j.pharmthera.2021.107808] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
63 Kiss B, Laszlovszky I, Krámos B, Visegrády A, Bobok A, Lévay G, Lendvai B, Román V. Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders. Biomolecules 2021;11:104. [PMID: 33466844 DOI: 10.3390/biom11010104] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
64 Guerrero-bautista R, Franco-garcía A, Hidalgo JM, Fernández-gómez FJ, Ribeiro Do Couto B, Núñez C, Milanés MV. Distinct regulation of dopamine D3 receptor in the basolateral amygdala and dentate gyrus during the reinstatement of cocaine CPP induced by drug priming and social stress.. [DOI: 10.1101/2021.01.08.425788] [Reference Citation Analysis]
65 Radwan B, Jansen G, Chaudhury D. Sleep-Wake Dynamics Pre- and Post-Exposure to Chronic Social Stress. SSRN Journal. [DOI: 10.2139/ssrn.3869114] [Reference Citation Analysis]
66 Liu S, Zhu J. Introduction. Dopamine in the Gut 2021. [DOI: 10.1007/978-981-33-6586-5_1] [Reference Citation Analysis]
67 Giorgioni G, Del Bello F, Pavletić P, Quaglia W, Botticelli L, Cifani C, Micioni Di Bonaventura E, Micioni Di Bonaventura MV, Piergentili A. Recent findings leading to the discovery of selective dopamine D4 receptor ligands for the treatment of widespread diseases. Eur J Med Chem 2021;212:113141. [PMID: 33422983 DOI: 10.1016/j.ejmech.2020.113141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
68 Nawaz R, Gul S, Amin R, Huma T, Al Mughairbi F. Overview of schizophrenia research and treatment in Pakistan. Heliyon 2020;6:e05545. [PMID: 33294688 DOI: 10.1016/j.heliyon.2020.e05545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Blasi C. Obesity and Related Type 2 Diabetes: A Failure of the Autonomic Nervous System Controlling Gastrointestinal Function? GastrointestDisord 2020;2:423-47. [DOI: 10.3390/gidisord2040039] [Reference Citation Analysis]
70 Brunetti P, Lo Faro AF, Tini A, Busardò FP, Carlier J. Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects. Pharmaceuticals (Basel) 2020;13:E309. [PMID: 33066617 DOI: 10.3390/ph13100309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]